Ginkgo Bioworks plans for AI is to focus on data. Per the company, data is the resource that powers machine learning applications. Large amounts of quality data make the fundamental difference for biological developers who create technologies that work, scale, reach the market and deliver for patients.
Many companies have begun utilizing AI in ingredient development already, such as Unilever and Cambrium, who have used the tools to sort through mass amounts of data in a much more efficent manner.
The company hopes to utilize this AI platform to deliver new therapeutics, green technologies, biosecurity tools and a range of products waiting to be built with biology.
Thomas Kurian, CEO of Google Cloud, commented: "Our strategic partnership with Ginkgo is a first-of-its-kind for Google Cloud, underscoring our confidence that Ginkgo will play a critical and pioneering role in the life sciences space, leveraging AI to reshape humanity’s understanding of biology.”